Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summaries
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis: Alzheimer’S Disease Therapeutics And Diagnostics Market
3.2. Market Definition
3.3. Key Drivers
3.3.1. Growing Geriatric Population
3.3.2. Rise In The Pervasiveness Of Alzheimer’S Disease
3.3.3. Emerging Novel Diagnostic Technologies
3.3.4. Increasing Pipeline Drugs
3.4. Key Restraints
3.4.1. Failure Of The Late-Stage Drugs
3.4.2. Stringent Government Regulations
3.4.3. High Cost Of Therapies Used For The Treatment Of Alzheimer’S Disease
4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Key Buying Criteria
4.2.1. Price
4.2.2. Efficiency
4.2.3. Safety
4.3. Etymology Of Alzheimer’S Disease Therapeutics And Diagnostics Market
4.4. Supply Chain Analysis
4.4.1. Research And Development
4.4.2. Raw Materials
4.4.3. Manufacturing
4.4.4. Wholesalers
4.4.5. End User
4.5. Phases And Sternness Of Alzheimer’S Disease
4.6. Opportunity Matrix
4.7. Vendor Landscape
4.8. Key Investment Insights
5. Market By Therapeutics And Diagnostics
5.1. Therapeutics
5.1.1. Therapeutics By Drugs
5.1.1.1. Marketed Drugs
5.1.1.2. Pipeline Drugs
5.1.2. Therapeutics By Disease Stage
5.1.2.1. Late Stage: Severe Ad
5.1.2.2. Early/Middle Stage: Mild To Moderate Ad
5.1.2.3. Prodromal Stage
5.1.3. Therapeutics By Generic And Branded
5.1.3.1. Branded
5.1.3.2. Generic
5.1.4. Diagnostics
5.1.4.1. Lumbar Puncture Test
5.1.4.2. Positron Emission Tomography
5.1.4.3. Electroencephalography
5.1.4.4. Magnetic Resonance Imaging
5.1.4.5. Computed Tomography
5.1.4.6. Other Diagnostics
6. Geographical Analysis
6.1. Europe
6.1.1. The United Kingdom
6.1.2. France
6.1.3. Germany
6.1.4. Italy
6.1.5. Russia
6.1.6. Belgium
6.1.7. Poland
6.1.8. Rest Of Europe
7. Company Profiles
7.1. Allergan Plc
7.2. Amarantus Bioscience Holdings Inc.
7.3. Baxter International Inc.
7.4. Biogen Inc.
7.5. Cognoptix, Inc.
7.6. Eisai Co. Ltd
7.7. Eli Lilly & Company
7.8. F. Hoffmann-La Roche
7.9. Ge Healthcare
7.10. Johnson & Johnson
7.11. Lupin Limited
7.12. Merck & Co. Inc.
7.13. Novartis Ag
7.14. Pfizer Inc.
7.15. Sun Pharmaceuticals Industries Ltd.

List of Tables
Table 1: Market Snapshot - Alzheimer’S Disease And Therapeutics
Table 2: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Therapeutics And Diagnostics, Historical Years, 2016-2019 (In $ Million)
Table 3: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Therapeutics And Diagnostics, Forecast Years, 2020-2028 (In $ Million)
Table 4: Europe Therapeutics Market, Historical Years, 2016-2019 (In $ Million)
Table 5: Europe Therapeutics Market, Forecast Years, 2020-2028 (In $ Million)
Table 6: Europe Therapeutics Market, By Drugs, Historical Years, 2016-2019 (In $ Million)
Table 7: Europe Therapeutics Market, By Drugs, Forecast Years, 2020-2028 (In $ Million)
Table 8: Europe Marketed Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 9: Europe Marketed Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 10: Europe Pipeline Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 11: Europe Pipeline Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 12: Europe Therapeutics Market, By Drugs, Historical Years, 2016-2019 (In $ Million)
Table 13: Europe Therapeutics Market, By Drugs, Forecast Years, 2020-2028 (In $ Million)
Table 14: Europe Late Stage Severe Ad Market, Historical Years, 2016-2019 (In $ Million)
Table 15: Europe Late Stage Severe Ad Market, Forecast Years, 2020-2028 (In $ Million)
Table 16: Europe Early/Middle Stage Mild To Moderate Ad Market, Historical Years, 2016-2019 (In $ Million)
Table 17: Europe Early/Middle Stage Mild To Moderate Ad Market, Forecast Years, 2020-2028 (In $ Million)
Table 18: Europe Prodromal Stage Market, Historical Years, 2016-2019 (In $ Million)
Table 19: Europe Prodromal Stage Market, Forecast Years, 2020-2028 (In $ Million)
Table 20: Europe Therapeutics Market, By Drugs, Historical Years, 2016-2019 (In $ Million)
Table 21: Europe Therapeutics Market, By Drugs, Forecast Years, 2020-2028 (In $ Million)
Table 22: Europe Branded Market, Historical Years, 2016-2019 (In $ Million)
Table 23: Europe Branded Market, Forecast Years, 2020-2028 (In $ Million)
Table 24: Europe Generic Market, Historical Years, 2016-2019 (In $ Million)
Table 25: Europe Generic Market, Forecast Years, 2020-2028 (In $ Million)
Table 26: Europe Diagnostics Market, Historical Years, 2016-2019 (In $ Million)
Table 27: Europe Diagnostics Market, Forecast Years, 2020-2028 (In $ Million)
Table 28: Europe Diagnostics Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 29: Europe Diagnostics Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 30: Europe Lumbar Puncture Test Market, Historical Years, 2016-2019 (In $ Million)
Table 31: Europe Lumbar Puncture Test Market, Forecast Years, 2020-2028 (In $ Million)
Table 32: Europe Positron Emission Tomography Market, Historical Years, 2016-2019 (In $ Million)
Table 33: Europe Positron Emission Tomography Market, Forecast Years, 2020-2028 (In $ Million)
Table 34: Europe Electroencephalography Market, Historical Years, 2016-2019 (In $ Million)
Table 35: Europe Electroencephalography Market, Forecast Years, 2020-2028 (In $ Million)
Table 36: Europe Magnetic Resonance Imaging Market, Historical Years, 2016-2019 (In $ Million)
Table 37: Europe Magnetic Resonance Imaging Market, Forecast Years, 2020-2028 (In $ Million)
Table 38: Europe Computed Tomography Market, Historical Years, 2016-2019 (In $ Million)
Table 39: Europe Computed Tomography Market, Forecast Years, 2020-2028 (In $ Million)
Table 40: Europe Other Diagnostics Market, Historical Years, 2016-2019 (In $ Million)
Table 41: Europe Other Diagnostics Market, Forecast Years, 2020-2028 (In $ Million)
Table 42: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 43: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Country, Forecast Years, 2020-2028 (In $ Million)

List of Figures
Figure 1: Pipeline Drugs Related To Alzheimer’S Disease
Figure 2: Costs Of Care For People With Alzheimer’S And Other Dementias, 2017 ($ Billion)
Figure 3: Porter’S Five Force Analysis
Figure 4: Supply Chain Analysis
Figure 5: Opportunity Matrix
Figure 6: Vendor Landscape
Figure 7: Key Investment Insights
Figure 8: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Therapeutics, 2020-2028 ($ Million)
Figure 9: Europe Therapeutics Market, By Marketed Drugs, 2020-2028 ($ Million)
Figure 10: Europe Therapeutics Market, By Pipeline Drugs, 2020-2028 ($ Million)
Figure 11: Europe Therapeutics Market, By Late Stage Severe Ad, 2020-2028 ($ Million)
Figure 12: Europe Therapeutics Market, By Early/Middle Stage: Mild To Moderate Ad, 2020-2028 ($ Million)
Figure 13: Europe Therapeutics Market, By Prodromal Stage, 2020-2028 ($ Million)
Figure 14: Europe Therapeutics Market, By Branded, 2020-2028 ($ Million)
Figure 15: Europe Therapeutics Market, By Generic, 2020-2028 ($ Million)
Figure 16: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Diagnostics, 2020-2028 ($ Million)
Figure 17: Europe Diagnostics Market, By Lumbar Puncture Test, 2020-2028 ($ Million)
Figure 18: Europe Diagnostics Market, By Positron Emission Tomography, 2020-2028 ($ Million)
Figure 19: Europe Diagnostics Market, By Electroencephalography, 2020-2028 ($ Million)
Figure 20: Europe Diagnostics Market, By Magnetic Resonance Imaging, 2020-2028 ($ Million)
Figure 21: Europe Diagnostics Market, By Computed Tomography, 2020-2028 ($ Million)
Figure 22: Europe Diagnostics Market, By Other Diagnostics, 2020-2028 ($ Million)
Figure 23: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, Country Outlook, 2019 & 2028 (In %)
Figure 24: The United Kingdom Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 25: France Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 26: Germany Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 27: Italy Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 28: Russia Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 29: Belgium Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 30: Poland Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 31: Rest Of Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)



List of Figures


Figure 1: Pipeline Drugs Related To Alzheimer’S Disease
Figure 2: Costs Of Care For People With Alzheimer’S And Other Dementias, 2017 ($ Billion)
Figure 3: Porter’S Five Force Analysis
Figure 4: Supply Chain Analysis
Figure 5: Opportunity Matrix
Figure 6: Vendor Landscape
Figure 7: Key Investment Insights
Figure 8: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Therapeutics, 2020-2028 ($ Million)
Figure 9: Europe Therapeutics Market, By Marketed Drugs, 2020-2028 ($ Million)
Figure 10: Europe Therapeutics Market, By Pipeline Drugs, 2020-2028 ($ Million)
Figure 11: Europe Therapeutics Market, By Late Stage Severe Ad, 2020-2028 ($ Million)
Figure 12: Europe Therapeutics Market, By Early/Middle Stage: Mild To Moderate Ad, 2020-2028 ($ Million)
Figure 13: Europe Therapeutics Market, By Prodromal Stage, 2020-2028 ($ Million)
Figure 14: Europe Therapeutics Market, By Branded, 2020-2028 ($ Million)
Figure 15: Europe Therapeutics Market, By Generic, 2020-2028 ($ Million)
Figure 16: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, By Diagnostics, 2020-2028 ($ Million)
Figure 17: Europe Diagnostics Market, By Lumbar Puncture Test, 2020-2028 ($ Million)
Figure 18: Europe Diagnostics Market, By Positron Emission Tomography, 2020-2028 ($ Million)
Figure 19: Europe Diagnostics Market, By Electroencephalography, 2020-2028 ($ Million)
Figure 20: Europe Diagnostics Market, By Magnetic Resonance Imaging, 2020-2028 ($ Million)
Figure 21: Europe Diagnostics Market, By Computed Tomography, 2020-2028 ($ Million)
Figure 22: Europe Diagnostics Market, By Other Diagnostics, 2020-2028 ($ Million)
Figure 23: Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, Country Outlook, 2019 & 2028 (In %)
Figure 24: The United Kingdom Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 25: France Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 26: Germany Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 27: Italy Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 28: Russia Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 29: Belgium Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 30: Poland Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)
Figure 31: Rest Of Europe Alzheimer’S Disease Therapeutics And Diagnostics Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - ALZHEIMER’S DISEASE AND THERAPEUTICS
TABLE 2: EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS AND DIAGNOSTICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS AND DIAGNOSTICS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: EUROPE THERAPEUTICS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: EUROPE THERAPEUTICS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: EUROPE THERAPEUTICS MARKET, BY DRUGS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE THERAPEUTICS MARKET, BY DRUGS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: EUROPE MARKETED DRUGS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: EUROPE MARKETED DRUGS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: EUROPE PIPELINE DRUGS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: EUROPE PIPELINE DRUGS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 12: EUROPE THERAPEUTICS MARKET, BY DRUGS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: EUROPE THERAPEUTICS MARKET, BY DRUGS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 14: EUROPE LATE STAGE SEVERE AD MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: EUROPE LATE STAGE SEVERE AD MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 16: EUROPE EARLY/MIDDLE STAGE MILD TO MODERATE AD MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: EUROPE EARLY/MIDDLE STAGE MILD TO MODERATE AD MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 18: EUROPE PRODROMAL STAGE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: EUROPE PRODROMAL STAGE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 20: EUROPE THERAPEUTICS MARKET, BY DRUGS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: EUROPE THERAPEUTICS MARKET, BY DRUGS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 22: EUROPE BRANDED MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: EUROPE BRANDED MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 24: EUROPE GENERIC MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: EUROPE GENERIC MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 26: EUROPE DIAGNOSTICS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: EUROPE DIAGNOSTICS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 28: EUROPE DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: EUROPE DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 30: EUROPE LUMBAR PUNCTURE TEST MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: EUROPE LUMBAR PUNCTURE TEST MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 32: EUROPE POSITRON EMISSION TOMOGRAPHY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: EUROPE POSITRON EMISSION TOMOGRAPHY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 34: EUROPE ELECTROENCEPHALOGRAPHY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: EUROPE ELECTROENCEPHALOGRAPHY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 36: EUROPE MAGNETIC RESONANCE IMAGING MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: EUROPE MAGNETIC RESONANCE IMAGING MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 38: EUROPE COMPUTED TOMOGRAPHY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: EUROPE COMPUTED TOMOGRAPHY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 40: EUROPE OTHER DIAGNOSTICS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: EUROPE OTHER DIAGNOSTICS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 42: EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)